Literature DB >> 33619332

Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.

Zarina Yelskaya1, Angela G Arnold2, Vanessa J Marcell2, Laura H Tang1, Erin E Salo-Mullen2, Vivian E Strong3, Zsofia K Stadler2, Liying Zhang4,5.   

Abstract

Hereditary Diffuse Gastric Cancer (HDGC) syndrome is associated with CDH1 germline likely pathogenic/pathogenic variants. Carriers of CDH1 germline likely pathogenic/pathogenic variants are predisposed to diffuse gastric cancer and lobular breast cancer. This study aims to classify the CDH1 c.[715G>A] missense variant identified in a diffuse gastric cancer prone family by performing splicing studies. RT-PCR and subsequent cloning experiments were performed to investigate whether this variant completely disrupts normal splicing. This variant preferentially abolishes normal splicing through activation of a cryptic 3' acceptor splice site within exon 6 of CDH1, presumably leading to a premature protein truncation within first extracellular domain repeat of E-cadherin protein. Our results contributed to evidence necessary to resolve pathogenicity classification of this variant, indicating that this variant is to be classified as pathogenic.
© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33619332      PMCID: PMC8298625          DOI: 10.1038/s41431-021-00825-w

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  15 in total

1.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

Review 2.  Familial gastric cancer: genetic susceptibility, pathology, and implications for management.

Authors:  Carla Oliveira; Hugo Pinheiro; Joana Figueiredo; Raquel Seruca; Fátima Carneiro
Journal:  Lancet Oncol       Date:  2015-02       Impact factor: 41.316

3.  Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients.

Authors:  Sollip Kim; Jun-Won Chung; Tae-Dong Jeong; Young-Soo Park; Jeong Hoon Lee; Ji Yong Ahn; Do Hoon Kim; Kee Don Choi; Woochang Lee; Ho June Song; Gin Hyug Lee; Sail Chun; Hwoon-Yong Jung; Won-Ki Min; Jin-Ho Kim
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 4.  The cell-cell adhesion molecule E-cadherin.

Authors:  F van Roy; G Berx
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

5.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

Authors:  Pardeep Kaurah; Andrée MacMillan; Niki Boyd; Janine Senz; Alessandro De Luca; Nicki Chun; Gianpaolo Suriano; Sonya Zaor; Lori Van Manen; Cathy Gilpin; Sarah Nikkel; Mary Connolly-Wilson; Scott Weissman; Wendy S Rubinstein; Courtney Sebold; Robert Greenstein; Jennifer Stroop; Dwight Yim; Benoit Panzini; Wendy McKinnon; Marc Greenblatt; Debrah Wirtzfeld; Daniel Fontaine; Daniel Coit; Sam Yoon; Daniel Chung; Gregory Lauwers; Antonio Pizzuti; Carlos Vaccaro; Maria Ana Redal; Carla Oliveira; Marc Tischkowitz; Sylviane Olschwang; Steven Gallinger; Henry Lynch; Jane Green; James Ford; Paul Pharoah; Bridget Fernandez; David Huntsman
Journal:  JAMA       Date:  2007-06-03       Impact factor: 56.272

6.  Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers.

Authors:  Maegan E Roberts; John Michael O Ranola; Megan L Marshall; Lisa R Susswein; Sara Graceffo; Kelsey Bohnert; Ginger Tsai; Rachel T Klein; Kathleen S Hruska; Brian H Shirts
Journal:  JAMA Oncol       Date:  2019-09-01       Impact factor: 31.777

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.

Authors:  Lisa R Susswein; Megan L Marshall; Rachel Nusbaum; Kristen J Vogel Postula; Scott M Weissman; Lauren Yackowski; Erica M Vaccari; Jeffrey Bissonnette; Jessica K Booker; M Laura Cremona; Federica Gibellini; Patricia D Murphy; Daniel E Pineda-Alvarez; Guido D Pollevick; Zhixiong Xu; Gabi Richard; Sherri Bale; Rachel T Klein; Kathleen S Hruska; Wendy K Chung
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

Review 9.  CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.

Authors:  Santosh Shenoy
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

Review 10.  Clinical spectrum and pleiotropic nature of CDH1 germline mutations.

Authors:  Joana Figueiredo; Soraia Melo; Patrícia Carneiro; Ana Margarida Moreira; Maria Sofia Fernandes; Ana Sofia Ribeiro; Parry Guilford; Joana Paredes; Raquel Seruca
Journal:  J Med Genet       Date:  2019-01-19       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.